RBC Capital Reiterates Outperform on Verisk Analytics, Maintains $210 Price Target
RBC Capital analyst Ashish Sabadra reiterates Verisk Analytics (NASDAQ:VRSK) with a Outperform and maintains $210 price target.
Looking Into Verisk Analytics’s Recent Short Interest
Verisk Analytics’s (NASDAQ:VRSK) short percent of float has risen 14.58% since its last report. The company recently reported…
Verisk Analytics Inks $2.5B Accelerated Share Repurchase Agreement
Verisk Analytics Inc (NASDAQ: VRSK) has entered into accelerated share repurchase agreements (ASR) with Citibank, N.A. and Goldman Sachs & Co. LLC.
JP Morgan Maintains Overweight on Verisk Analytics, Raises Price Target to $200
JP Morgan analyst Andrew Steinerman maintains Verisk Analytics (NASDAQ:VRSK) with a Overweight and raises the price target from $195 to $200.
BMO Capital Maintains Market Perform on Verisk Analytics, Lowers Price Target to $188
BMO Capital analyst Jeffrey Silber maintains Verisk Analytics (NASDAQ:VRSK) with a Market Perform and lowers the price target from $191 to $188.
Redburn Partners Initiates Coverage On Verisk Analytics with Sell Rating
Redburn Partners analyst Russell Quelch initiates coverage on Verisk Analytics (NASDAQ:VRSK) with a Sell rating.
Morgan Stanley Maintains Equal-Weight on Verisk Analytics, Raises Price Target to $181
Morgan Stanley analyst Toni Kaplan maintains Verisk Analytics (NASDAQ:VRSK) with a Equal-Weight and raises the price target from $170 to $181.
Verisk Agrees to Acquire Swedish InsurTech Mavera; Terms Not Disclosed
Verisk (Nasdaq: VRSK), a leading global data analytics provider, has entered into an agreement to acquire Mavera, a Sweden-based InsurTech firm with a strong regional presence and established customer base for its personal injury claims management platform.
7 Analysts Have This to Say About Verisk Analytics
Verisk Analytics (NASDAQ:VRSK) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Verisk’s AI-Powered Innovation Cuts Medical Records Review Time By Up To 90%
Insurance claims professionals can now extract critical insights from lengthy medical records – in minutes rather than hours – with the help of artificial intelligence (AI) and deep clinical expertise of